Avita Announces Five RECELL® Abstracts Accepted for Presentation at American Burn Association (ABA) 50th Annual Meeting

Valencia, CA, USA, and Melbourne, Australia, 30 January 2018 — Avita Medical (ASX – AVH, OTCQX: AVMXY) announced that five abstracts highlighting the compelling clinical data and health economic benefits of RECELL® in the treatment of burns have been accepted for presentation at the American Burn Association 50th Annual Meeting to be held from April […]

AmpliPhi Biosciences Announces Pricing of $4.0 Million Public Offering of Common Stock

CATEGORY: Featured Wednesday, January 10, 2018 6:00 am EST SAN DIEGO EmailPDFPrintRSS PUBLIC COMPANY INFORMATION: NYSEAM: APHB SAN DIEGO–(BUSINESS WIRE)–AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced the pricing of a public offering of 4,000,000 shares of its common stock, offered at […]

AmpliPhi Biosciences Announces Proposed Public Offering of Common Stock

CATEGORY: Featured Tuesday, January 9, 2018 5:13 pm EST SAN DIEGO EmailPDFPrintRSS PUBLIC COMPANY INFORMATION: NYSEAM: APHB SAN DIEGO–(BUSINESS WIRE)–AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that it intends to offer shares of its common stock in a public offering. H.C. […]

AmpliPhi Biosciences Announces Positive Interim Results for Single-Patient Expanded Access Program Utilizing AB-SA01 and AB-PA01

 Seven patients with serious, life-threatening infections, not responding to antibiotics, were treated with AB-SA01 or AB-PA01, with six patients, 86%, achieving treatment success  Treatment was well tolerated in all patients, with over 500 doses administered intravenously or inhalation  AmpliPhi expects to continue its expanded access clinical strategy in 2018, review data with the FDA […]